Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clinuvel Pharmaceuticals.
RELATED STOCKHEAD STORIES
Experts
Criterion’s small cap gems poised to star in 2025 (part one)
News
ASX Lunch Wrap: Curve ball thrown as new bank levy bites; Alderan jumps on US copper hit
Health & Biotech
Health Check: Which biotech boards are at risk of a ‘second strike’?
Health & Biotech
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human trial
Health & Biotech
Health Check: 4D Medical investors – and burns pit victims – can breathe easier after US lung-imaging deal
Health & Biotech
Alive and Kicking: ‘We are not alone in going through a lull in markets’, says Clinuvel chair
Health & Biotech
ASX Health Stocks: Clinuvel, MedAdvisor rally after hitting high notes on profits
Health & Biotech
ASX Health Stocks: Amplia’s pancreatic cancer drug shows progress
News
ASX Small Caps Lunch Wrap: Has Japan unleashed a new colossal death robot this week?
Health & Biotech
ASX Health Stocks: Cardiex jumps 15pc on sales update; Recce’s drug included in WHO’s report
Health & Biotech
ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat in ‘up and down’ reporting season
News
Short & Caught: Pilbara Minerals ASX’s most shorted as lithium stocks targeted
News
Brokers on Monday: Clinuvel finds friends; ANZ’s unimpressive outlook
Health & Biotech
ScoPo’s Powerplays: Could ASX health stocks up for third week be a start of a Christmas rally?
Health & Biotech
ScoPo’s Powerplays: Should have stayed in bed as ASX stocks fall but Neuren makes S&P ASX 200
News
